Novel Anti-Prostate Cancer Curcumin Analogues That Enhance Androgen Receptor Degradation Activity

    Qian Shi, Charles C.-Y. Shih, K H Lee
    Studysummary This study found that new curcumin analogues, such as ASC-J9, can inhibit prostate cancer cell growth by promoting androgen receptor degradation. Our plain-language summary of this paper — not a Tressless recommendation.
    The document discussed the role of the androgen receptor (AR) in various physiological and pathological conditions, including androgenetic alopecia and prostate cancer. It highlighted that while many curcumin analogues were known for their anticancer properties, they typically worked through general cytotoxic effects. However, new curcumin analogues, such as ASC-J9 and its analogues, were found to inhibit prostate cancer proliferation by specifically enhancing AR degradation, representing a novel mechanism of action.
    Discuss this study in the Community →